The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Dr Will Nutland Discusses Enhanced Outreach to Queer Migrant Men Living With HIV in London

July 1st 2022, 11:01am


Will Nutland, DrPH, is cofounder of PrEPster, honorary assistant professor at the London School of Hygiene and Tropical Medicine, and an activist.

Risk for CVD Increases Following INSTI Use for HIV

June 28th 2022, 12:41pm


A possible connection between integrase strand-transfer inhibitor (INSTI) use for HIV and cardiovascular disease (CVD) was investigated in this new study from an international team wanting more knowledge on the drug class’s treatment effects.

What We’re Reading: Bipartisan Gun Law Passes Senate; HIV Cases Dropped During Pandemic; COVID-19 Vaccines Save 20 Million Lives

June 24th 2022, 2:55pm


The Senate passed a bipartisan gun law, the first major gun legislation in nearly 30 years, which now goes to the House; HIV cases dropped during the pandemic, perhaps due to lack of testing; researchers say COVID-19 vaccines have saved nearly 20 million lives but could be even more effective.

Meningococcal Vaccine Uptake Lagging Among People Living With HIV

June 23rd 2022, 11:53pm


The findings of this study, which used insurance claims data for patients 2 years and older to determine rates of meningococcal A, C, W, Y vaccine uptake, points to the need for more education, the authors said.

Canada’s Bruce House: U=U Is Fundamental to What We Do

June 20th 2022, 7:31pm


Bruce House in Ottawa, Ontario, Canada, has been serving individuals living with HIV and AIDS for 34-plus years. Here we speak with Patrick Morley, office and communications coordinator.

Emerging Nonepidemic Kaposi Sarcoma Subtype Shows Favorable Outcomes According to Study

June 18th 2022, 6:47pm


Researchers emphasize the importance of characterizing and recognizing this subtype to identify patients at risk of Kaposi sarcoma.

Anal Cancer Risk in PLWH Halved Following Precancerous Lesion Treatment

June 15th 2022, 9:00pm


The new trial was the first to investigate outcomes among a patient population living with HIV (PLWH) who were treated for anal precancerous growths, or high-grade squamous intraepithelial lesions.

CHIVA’s Amanda Ely Addresses Difficulties Involved With Telling Children They Have HIV

June 11th 2022, 12:12pm


Amanda Ely is CEO of the Children’s HIV Association (CHIVA), an organization that provides support to children living with HIV in the United Kingdom and Ireland and their families.

What We’re Reading: Rectal Cancer Drug Results Released; Military HIV Policies Updated; Executive Order on Abortion Rights

June 9th 2022, 2:44pm


An experimental cancer drug made 100% of patients’ rectal tumors disappear in a small study; US military members with HIV with an undetectable viral load and no symptoms will no longer face restrictions in deployment or commission; President Biden may sign an executive order on abortion rights depending on the Supreme Court’s ruling.

Anti-HIV Antibody Combination Leads to Long-term HIV Suppression, Researchers Find

June 3rd 2022, 7:14pm


A small study found that 2 broadly neutralizing anti-HIV antibodies could help achieve long-term virological suppression in patients with HIV who were taken off antiretroviral therapy.